IBDEI119 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37466,2)
 ;;=^5001059
 ;;^UTILITY(U,$J,358.3,37467,0)
 ;;=C44.622^^138^1853^15
 ;;^UTILITY(U,$J,358.3,37467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37467,1,3,0)
 ;;=3^SCC Skin Right Upper Limb
 ;;^UTILITY(U,$J,358.3,37467,1,4,0)
 ;;=4^C44.622
 ;;^UTILITY(U,$J,358.3,37467,2)
 ;;=^5001070
 ;;^UTILITY(U,$J,358.3,37468,0)
 ;;=C44.629^^138^1853^6
 ;;^UTILITY(U,$J,358.3,37468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37468,1,3,0)
 ;;=3^SCC Skin Left Upper Limb
 ;;^UTILITY(U,$J,358.3,37468,1,4,0)
 ;;=4^C44.629
 ;;^UTILITY(U,$J,358.3,37468,2)
 ;;=^5001071
 ;;^UTILITY(U,$J,358.3,37469,0)
 ;;=C44.722^^138^1853^14
 ;;^UTILITY(U,$J,358.3,37469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37469,1,3,0)
 ;;=3^SCC Skin Right Lower Limb
 ;;^UTILITY(U,$J,358.3,37469,1,4,0)
 ;;=4^C44.722
 ;;^UTILITY(U,$J,358.3,37469,2)
 ;;=^5001082
 ;;^UTILITY(U,$J,358.3,37470,0)
 ;;=C44.729^^138^1853^5
 ;;^UTILITY(U,$J,358.3,37470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37470,1,3,0)
 ;;=3^SCC Skin Left Lower Limb
 ;;^UTILITY(U,$J,358.3,37470,1,4,0)
 ;;=4^C44.729
 ;;^UTILITY(U,$J,358.3,37470,2)
 ;;=^5001083
 ;;^UTILITY(U,$J,358.3,37471,0)
 ;;=C44.82^^138^1853^10
 ;;^UTILITY(U,$J,358.3,37471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37471,1,3,0)
 ;;=3^SCC Skin Overlapping Sites
 ;;^UTILITY(U,$J,358.3,37471,1,4,0)
 ;;=4^C44.82
 ;;^UTILITY(U,$J,358.3,37471,2)
 ;;=^5001089
 ;;^UTILITY(U,$J,358.3,37472,0)
 ;;=L57.8^^138^1853^22
 ;;^UTILITY(U,$J,358.3,37472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37472,1,3,0)
 ;;=3^Skin Changes d/t Chr Exposure to Nonionizing Radiation
 ;;^UTILITY(U,$J,358.3,37472,1,4,0)
 ;;=4^L57.8
 ;;^UTILITY(U,$J,358.3,37472,2)
 ;;=^5009226
 ;;^UTILITY(U,$J,358.3,37473,0)
 ;;=L27.0^^138^1853^23
 ;;^UTILITY(U,$J,358.3,37473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37473,1,3,0)
 ;;=3^Skin Eruption,Generalized d/t Drugs/Meds Taken Internally
 ;;^UTILITY(U,$J,358.3,37473,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,37473,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,37474,0)
 ;;=L27.1^^138^1853^24
 ;;^UTILITY(U,$J,358.3,37474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37474,1,3,0)
 ;;=3^Skin Eruption,Localized d/t Drugs/Meds Taken Internally
 ;;^UTILITY(U,$J,358.3,37474,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,37474,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,37475,0)
 ;;=L51.1^^138^1853^29
 ;;^UTILITY(U,$J,358.3,37475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37475,1,3,0)
 ;;=3^Stevens-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,37475,1,4,0)
 ;;=4^L51.1
 ;;^UTILITY(U,$J,358.3,37475,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,37476,0)
 ;;=L51.3^^138^1853^30
 ;;^UTILITY(U,$J,358.3,37476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37476,1,3,0)
 ;;=3^Stevens-Johnson Syndrome-Toxic Epdrml Necrolysis Overlap Syndrome
 ;;^UTILITY(U,$J,358.3,37476,1,4,0)
 ;;=4^L51.3
 ;;^UTILITY(U,$J,358.3,37476,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,37477,0)
 ;;=Z12.83^^138^1853^19
 ;;^UTILITY(U,$J,358.3,37477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37477,1,3,0)
 ;;=3^Screening for Malig Neop of Skin
 ;;^UTILITY(U,$J,358.3,37477,1,4,0)
 ;;=4^Z12.83
 ;;^UTILITY(U,$J,358.3,37477,2)
 ;;=^5062696
 ;;^UTILITY(U,$J,358.3,37478,0)
 ;;=Z48.817^^138^1853^33
 ;;^UTILITY(U,$J,358.3,37478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37478,1,3,0)
 ;;=3^Surgical Aftercare Following Skin Surgery
 ;;^UTILITY(U,$J,358.3,37478,1,4,0)
 ;;=4^Z48.817
 ;;^UTILITY(U,$J,358.3,37478,2)
 ;;=^5063054
 ;;^UTILITY(U,$J,358.3,37479,0)
 ;;=L94.0^^138^1853^18
 ;;^UTILITY(U,$J,358.3,37479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37479,1,3,0)
 ;;=3^Scleroderma,Localized
 ;;^UTILITY(U,$J,358.3,37479,1,4,0)
 ;;=4^L94.0
 ;;^UTILITY(U,$J,358.3,37479,2)
 ;;=^5009470
 ;;^UTILITY(U,$J,358.3,37480,0)
 ;;=D23.9^^138^1853^20
 ;;^UTILITY(U,$J,358.3,37480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37480,1,3,0)
 ;;=3^Sebaceous Hyperplasia
 ;;^UTILITY(U,$J,358.3,37480,1,4,0)
 ;;=4^D23.9
 ;;^UTILITY(U,$J,358.3,37480,2)
 ;;=^5002076
 ;;^UTILITY(U,$J,358.3,37481,0)
 ;;=L21.9^^138^1853^21
 ;;^UTILITY(U,$J,358.3,37481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37481,1,3,0)
 ;;=3^Seborrhea,Unspec
 ;;^UTILITY(U,$J,358.3,37481,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,37481,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,37482,0)
 ;;=L91.8^^138^1853^25
 ;;^UTILITY(U,$J,358.3,37482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37482,1,3,0)
 ;;=3^Skin Tag
 ;;^UTILITY(U,$J,358.3,37482,1,4,0)
 ;;=4^L91.8
 ;;^UTILITY(U,$J,358.3,37482,2)
 ;;=^5009460
 ;;^UTILITY(U,$J,358.3,37483,0)
 ;;=I83.12^^138^1853^28
 ;;^UTILITY(U,$J,358.3,37483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37483,1,3,0)
 ;;=3^Stasis Dermatitis.Left Leg
 ;;^UTILITY(U,$J,358.3,37483,1,4,0)
 ;;=4^I83.12
 ;;^UTILITY(U,$J,358.3,37483,2)
 ;;=^5007989
 ;;^UTILITY(U,$J,358.3,37484,0)
 ;;=I83.11^^138^1853^27
 ;;^UTILITY(U,$J,358.3,37484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37484,1,3,0)
 ;;=3^Stasis Dermatitis,Right Leg
 ;;^UTILITY(U,$J,358.3,37484,1,4,0)
 ;;=4^I83.11
 ;;^UTILITY(U,$J,358.3,37484,2)
 ;;=^5007988
 ;;^UTILITY(U,$J,358.3,37485,0)
 ;;=B35.1^^138^1854^9
 ;;^UTILITY(U,$J,358.3,37485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37485,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,37485,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,37485,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,37486,0)
 ;;=F63.3^^138^1854^12
 ;;^UTILITY(U,$J,358.3,37486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37486,1,3,0)
 ;;=3^Trichotillomania
 ;;^UTILITY(U,$J,358.3,37486,1,4,0)
 ;;=4^F63.3
 ;;^UTILITY(U,$J,358.3,37486,2)
 ;;=^5003643
 ;;^UTILITY(U,$J,358.3,37487,0)
 ;;=B35.2^^138^1854^6
 ;;^UTILITY(U,$J,358.3,37487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37487,1,3,0)
 ;;=3^Tinea Manuum
 ;;^UTILITY(U,$J,358.3,37487,1,4,0)
 ;;=4^B35.2
 ;;^UTILITY(U,$J,358.3,37487,2)
 ;;=^5000605
 ;;^UTILITY(U,$J,358.3,37488,0)
 ;;=B35.6^^138^1854^5
 ;;^UTILITY(U,$J,358.3,37488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37488,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,37488,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,37488,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,37489,0)
 ;;=B35.3^^138^1854^8
 ;;^UTILITY(U,$J,358.3,37489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37489,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,37489,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,37489,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,37490,0)
 ;;=B35.4^^138^1854^4
 ;;^UTILITY(U,$J,358.3,37490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37490,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,37490,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,37490,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,37491,0)
 ;;=L51.2^^138^1854^11
 ;;^UTILITY(U,$J,358.3,37491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37491,1,3,0)
 ;;=3^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,37491,1,4,0)
 ;;=4^L51.2
 ;;^UTILITY(U,$J,358.3,37491,2)
 ;;=^5009206
 ;;^UTILITY(U,$J,358.3,37492,0)
 ;;=B35.0^^138^1854^2
 ;;^UTILITY(U,$J,358.3,37492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37492,1,3,0)
 ;;=3^Tinea Barae/Capitis
 ;;^UTILITY(U,$J,358.3,37492,1,4,0)
 ;;=4^B35.0
 ;;^UTILITY(U,$J,358.3,37492,2)
 ;;=^5000604
 ;;^UTILITY(U,$J,358.3,37493,0)
 ;;=B36.3^^138^1854^3
 ;;^UTILITY(U,$J,358.3,37493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37493,1,3,0)
 ;;=3^Tinea Blanca
 ;;^UTILITY(U,$J,358.3,37493,1,4,0)
 ;;=4^B36.3
 ;;^UTILITY(U,$J,358.3,37493,2)
 ;;=^266864
 ;;^UTILITY(U,$J,358.3,37494,0)
 ;;=B36.1^^138^1854^7
 ;;^UTILITY(U,$J,358.3,37494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37494,1,3,0)
 ;;=3^Tinea Nigra
 ;;^UTILITY(U,$J,358.3,37494,1,4,0)
 ;;=4^B36.1
 ;;^UTILITY(U,$J,358.3,37494,2)
 ;;=^264999
 ;;^UTILITY(U,$J,358.3,37495,0)
 ;;=B36.0^^138^1854^10
 ;;^UTILITY(U,$J,358.3,37495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37495,1,3,0)
 ;;=3^Tinea Veriscolor
